Rohit Aggarwal, MD, MS

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Capella Bioscience
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Capstanx
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Corbus
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    CSL Behring
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    EMD Serono
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    EMD Serono
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Galapagos
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Horizon Therapeutics
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    I-Cell
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Immunovant
    Date added:
    04/04/2024
    Date updated:
    08/20/2024

Pages

Return to 2024 Inova Fairfax MGR (Enduring Material): Recent Updates in Myositis